2008-2009 New Drug Approvals
1 Modeling and Simulation: Tool for Optimized Drug Development Martin Roessner Biostatistics sanofi aventis Bridgewater, NJ.
Development of Pediatric ARV Drugs – FDA Perspective Linda L. Lewis, M.D. Medical Officer Division of Antiviral Drug Products U.S. Food and Drug Administration.
1 Cross Labeling Combination Products and User Fees Bradley Merrill Thompson, MBA, JD, RAC Epstein Becker & Green PC Pharma MedDevice 2007 Conference New.
Training Workshop on Pharmaceutical Development with a Focus on Paediatric Medicines 15-19 October 2007 Slide 1 Training Workshop on Pharmaceutical Development.
Fast Dissolving Oral Film Of Donepezil HCl By Swapnil Patil
Ranbaxy singapore
Investigational new drug application new
Protein therapeutics
Actemra125472Orig1s000
Overview of Protein Therapeutics 1. Contents Introduction 1 Production 2 Delivery 33 Future Direction 44.
Dr. Basavaraj K. Nanjwade M. Pharm., PhD KLE University College of Pharmacy BELGAUM-590010, Karnataka, India. E-mail: [email protected]@gmail.com.
